Text Size
20 studies found for:    Open Studies | "Polycystic Kidney Diseases"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting 8-Week Study of Tolvaptan Dose Forms in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Condition: Autosomal Dominant Polycystic Kidney Disease
Interventions: Drug: Tolvaptan MR;   Drug: Tolvaptan IR;   Drug: Placebo
2 Recruiting Clinical and Molecular Investigations Into Ciliopathies
Conditions: Autosomal Recessive Polycystic Kidney Disease;   Congenital Hepatic Fibrosis;   Caroli's Disease;   Polycystic Kidney Disease;   Joubert Syndrome;   Cerebro-Oculo-Renal Syndromes;   COACH Syndrome;   Senior-Loken Syndrome;   Dekaban-Arima Syndrome;   Cogan Oculomotor Apraxia;   Nephronophthisis;   Bardet-Biedl Syndrome;   Alstrom Syndrome;   Oral-Facial-Digital Syndrome
Intervention:
3 Recruiting Somatostatin In Patients With Autosomal Dominant Polycystic Kidney Disease And Moderate To Severe Renal Insufficiency
Condition: Autosomal Dominant Polycystic Kidney Disease.
Interventions: Drug: Octreotide-LAR;   Other: Saline solution.
4 Recruiting Randomized Clinical Trial of Triptolide Woldifii for Autosomal Dominant Polycystic Kidney Disease
Condition: Polycystic Kidney
Interventions: Drug: tripterygium wilfordii;   Drug: Emodin
5 Recruiting Polycystic Kidney Disease Data Repository
Condition: Polycystic Kidney Disease
Intervention:
6 Recruiting Bosutinib For Autosomal Dominant Polycystic Kidney Disease
Condition: Polycystic Kidney, Autosomal Dominant
Interventions: Drug: Bosutinib;   Drug: Placebo
7 Recruiting A Safety, Pharmacokinetic and Dose-Escalation Study of KD019 in Subjects With Autosomal Dominant Polycystic Kidney Disease
Condition: Polycystic Kidney, Autosomal Dominant
Intervention: Drug: KD019
8 Unknown † Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD): The Role of Biomarkers in Predicting a Response to Therapy
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention: Drug: Rapamycin
9 Recruiting Study of Lanreotide to Treat Polycystic Kidney Disease
Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Intervention: Drug: Lanreotide
10 Recruiting Efficacy Study of Water Drinking on PKD Progression.
Conditions: Autosomal Dominant Polycystic Kidney Disease.;   Disease Progression
Intervention:
11 Recruiting Everolimus on CKD Progression in ADPKD Patients
Condition: Polycystic Kidney Diseases
Interventions: Drug: Everolimus;   Drug: Standard Therapy
12 Recruiting UAB HRFD Core Center: Core A: The Hepato/Renal Fibrocystic Diseases Translational Resource
Conditions: Hepato/Renal Fibrocystic Disease;   Autosomal Recessive Polycystic Kidney Disease;   Joubert Syndrome;   Bardet Biedl Syndrome;   Meckel-Gruber Syndrome;   Congenital Hepatic Fibrosis;   Caroli Syndrome;   Oro-Facial-Digital Syndrome Type I;   Nephronophthisis;   Glomerulocystic Kidney Disease
Intervention:
13 Recruiting Pasireotide LAR in Severe Polycystic Liver Disease
Conditions: Somatostatin Analogs;   Polycystic Liver Disease;   Autosomal Dominant Polycystic Kidney Disease;   Autosomal Dominant Polycystic Liver Disease
Interventions: Drug: Pasireotide LAR;   Drug: Placebo
14 Recruiting Sirolimus for Massive Polycystic Liver
Condition: Polycystic Kidney Diseases
Intervention: Drug: Sirolimus
15 Recruiting Transplant Patient Registry of Liver, Kidney and/or Pancreas
Conditions: Hepatitis B;   Hepatitis C;   Liver Cirrhosis;   Hepatocellular Carcinoma;   Polycystic Kidney Diseases
Intervention:
16 Unknown † Efficacy and Safety Study of Second-Line Treatment for Hypertension With Autosomal Dominant Polycystic Kidney Disease(ADPKD)
Condition: Kidney, Polycystic, Autosomal Dominant
Interventions: Drug: Cilnidipine;   Drug: Imidapril
17 Recruiting A New Diet for Patients With Autosomal Dominant Polycystic Disease (ADPKD)
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention: Other: ADPKD Diet
18 Not yet recruiting Mineralocorticoid Antagonism and Endothelial Dysfunction in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Condition: ADPKD
Interventions: Drug: Spironolactone;   Drug: Sugar pill
19 Unknown † Clinical Trial to Slow the Progression of ADPKD
Conditions: Kidney, Polycystic;   Kidney, Polycystic, Autosomal Dominant
Intervention: Drug: anti-hypertensive medications
20 Unknown † CCB Safety Study in Treatment of Hypertension of ADPKD
Condition: Kidney, Polycystic, Autosomal Dominant
Interventions: Drug: Candesartan;   Drug: Candesartan and Cilnidipine;   Drug: Candesartan plus non-CCB agents
To Top

† Indicates status has not been verified in more than two years